Make Innovation and Patients a Priority in 2017:
Repeal the Medical Device Tax

Last year, Congress advanced patient care by temporarily suspending the medical device excise tax – allowing companies to invest in R&D, re-start delayed projects, and create jobs.

We urge Congress to move quickly in 2017 to fully repeal the medical device tax. Doing so will provide certainty for companies making decisions affecting tomorrow’s life-changing medical technologies.

“Simply put, today’s announcement is proof that the medical device tax needs to be permanently repealed so Welch Allyn will remain a source of economic energy for Central New York for years to come.”

Sen. Charles Schumer, D-NY
Statement responding to news about Welch Allyn adding 100 new jobs to its medical equipment factory in Skaneateles, NY

“Our continued investment in this collaboration [with the Mayo Clinic] is an example of our commitment to further investing in jobs and innovation as a result of the recent suspension of the medical device tax.”

Michael Mahoney
President and CEO, Boston Scientific, on doubling the company’s research collaboration
to develop new technologies to help thousands of cardiovascular patients

“This critical relief [from the device tax] is extremely important to BD, as well as the patients, providers and research communities we serve. We are already reinvesting the savings…into a number of R&D projects including medication management and genomics.”

Vincent Forlenza
Chairman, CEO and President, BD

“Suspension of the medical device tax will greatly benefit our patients, who are children. Instead of paying hundreds of thousands of dollars in excise tax, we can now use that money to increase substantially our development of new products that help kids.”

Mark Throdahl
President and CEO, OrthoPediatrics

“When I heard…that this excise tax freeze was going through, just last week, I signed the contract with this R&D firm…. I’m going to take that money and I’m going to create jobs.”


“[Thanks to the suspension of the device tax], the company will materially increase its R&D budget in 2016 over 2015. Employees will receive a pay increase above the US and industry average and the largest pay increase in recent memory.”

Caroll Neubauer
Chairman and Chief Executive Officer of B. Braun of America




Learn more about the value of medical technology and device tax repeal efforts. Sign up for our monthly newsletter.